Field work in progress on the Gold Aquilon Property, Eeyou Istchee James Bay region, Quebec
MONTREAL, Oct. 03, 2024 (GLOBE NEWSWIRE) — The management of Sirios Resources Inc. (TSX-V: SOI) is pleased to announce the […]
Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events
Bright Minds Biosciences will present scientific posters about various programs in development, including BMB-101, BMB-201 and BMB-202 Bright Minds Biosciences […]
SAGA Metals Completes Field Program at North Wind Iron Ore Project and Lists on Frankfurt Stock Exchange
VANCOUVER, British Columbia, Oct. 03, 2024 (GLOBE NEWSWIRE) — SAGA Metals Corp. (“TSXV: SAGA”) (“FSE: 20H”) (“SAGA” or the “Company”), […]
Grayscale Investments® Launches Grayscale® Aave Trust
STAMFORD, Conn., Oct. 03, 2024 (GLOBE NEWSWIRE) — Grayscale Investments®, an asset management firm with expertise in crypto investing, offering […]
AMERANT BANK EARNS SPOT ON NEWSWEEK’S 2024 LIST OF AMERICA’S MOST LOVED WORKPLACES FOR THE THIRD CONSECUTIVE YEAR
Miami, FL, Oct. 03, 2024 (GLOBE NEWSWIRE) — Newsweek recently announced their annual rankings of 2024 America’s Top Most Loved […]
Minerals Technologies Announces Third Quarter 2024 Conference Call
NEW YORK, Oct. 03, 2024 (GLOBE NEWSWIRE) — Minerals Technologies Inc. (NYSE: MTX) (“MTI” or “the Company”) announced today that it […]
Le CN divulguera ses résultats financiers et d’exploitation du troisième trimestre de 2024 le 22 octobre 2024
MONTRÉAL, 03 oct. 2024 (GLOBE NEWSWIRE) — Le CN (TSX : CNR) (NYSE : CNI) divulguera ses résultats financiers et d’exploitation du troisième […]
CN to Report Third-Quarter 2024 Financial and Operating Results on October 22, 2024
MONTREAL, Oct. 03, 2024 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) will issue its third-quarter 2024 financial and operating […]
TSX News -
TC Transcontinental’s Near-Term Emissions Targets Approved by the Science Based Targets initiative (SBTi)
MONTRÉAL, Oct. 03, 2024 (GLOBE NEWSWIRE) — Transcontinental inc. (TSX: TCL.A TCL.B) announces an important milestone in its sustainability journey. […]
AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis
OCALA, Fla., Oct. 03, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that […]
